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853-6 Predictors and Sequelae of Subacute Thrombosis After 
Percutaneous Intervention in Acute Myocardial 
Infarction: The CADILLAC Trial 
Eve D. Avmonq, Cindy L. Grines, David A. Cox, Eulogia Garcra, James E. Tcheng, John 
J. Griffin, Giulio Guagliumi, Thomas D. Stuckey, Mark Turco, John D. Carroll, Barry D. 
Rutherford, Alexandra J. Lansky Roxana Mehran, Gregg W. Stone, The CADILLAC 
Investigators, Cardiovascular Research Foundation, New York, NY 
Background: Subacute thrombosis (SAT) after elective PCI is a rare event with devas- 
tating consequences. Little is known about SAT after AMI intervention. 
Methods: In the CADILLAC tnal 2062 pts with AMI cl2 hours were prospectively ran- 
domized to PTCA + abcrximab (abcx) vs. MultiLink stenting + abcx. SAT and major car- 
diac events were adjudicated by an independent committee. 
Results: SAT occurred rn 19 patients, 0.9% of the entire study population. The median 
time to SAT was 2 days (range 0 - 23 days). From more than 50 baseline clinical, pre 
and post procedural variables examined, the only predictor of SAT was smaller device 
size (3 vs. 3.5mm, p=O.Ol). SAT rates were 1.9% with PTCA, 0.8% with stent, 1 .O% with 
PTCAIabcx, and 0% with stenVabcx (p=O.Ol). In pooled analysis, SAT occurred in 0.48% 
of pts after stenting vs. 1.34% after PTCA (p=O.O6), and in 0.38% with abcx vs. 1.46% 
without abcx (p=O.Ol). In multwanate logtstic regression analysis, randomization to abcx 
had a significant protective effect (OR [95%CI] = 0.26 [0.09, 0.801, p=O.O2). as did larger 
devrce size. Compared to pts without SAT, pts with SAT had greater l-year rates of rein- 
farction (32.4% vs. 2.1%, pcO.OOOl), death from reinfarction (5.4% vs. 0.3%, p=O.O02), 
ischemic NR (91.9% vs. 12.6% p<O.OOOl). and less recovery in Infarct wall motion at 
follow-up angtography (-0.62 vs. 0.39 stdichord, p=O.O3). 
Conclusions: Subacute thrombosis is a rare but hazardous occurrence following percu- 
taneous intervention in AMI, resulting in a marked increase rn major adverse events and 
diminrshed myocardial recovery. Abciximab use and larger devices are preventative of 
SAT m this patient populatron. 
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1194-96 lschemic Preconditioning and T4 Pretreatment Have 
Additive Cardioprotective Effects Against lschemia 
Probably Mediated by Incremental ~33 MAPK 
Attenuation 
loannis P&is. Costas Pantos, Vassiliki Malliopoulou, Evangelia Karamanoli, Panagiotis 
Morattis, Dennis Varonos, Dennis V. Cokkinoa Medical School of Athens, Athens, 
Greece, Onassrs Cardiac Surgery Center, Athens, Greece 
Background: Long-term thyroxine adminrstration has been shown to protect the head 
agaist ischaemic injury. This cardioprotection is associated with decreased activation of 
p38 MAPK during ischaemia (I) and reperfusion (R). lschaemic preconditioning (PC) is 
another cardioprotective mechanism associated with ~38 MAPK attenuation. We investi- 
gated whether these two mechanisms exert an additive effect and if this effect is associ- 
ated with further decrease in ~38 MAPK activation In response to I-R in the isolated rat 
heart. 
Methods: Male W&tar rats were treated with L-Thyroxine (25pg/lOOg) subcutaneously 
once daily for 14 days (THYR); normal rats treated with normal saline served as controls 
(NORM). The isolated hearts were perfused in the Langendorff mode and subjected to 
the following protocols: 1) 20 min of stabilization followed by 20 min of zero-flow global I, 
NORM(I), n=4 and THYRQ). n=4 2) 20 min of stabilisation followed by 20 min of I and 45 
min of R. NORM(I/R), n=6 and THYR(I/R), n=6 3) 20 min of stabilisation followed by two 
cycles of PC (3min I, 5mrn A, Bmin I, 5min R) and then 20 min of I, THYR-PC(I), n=4 and 
4) 20 min of stabilisation followed by PC, 20 mm of I and 45 min of R, THYR-PC(I/R). 
n=6. Postrschaemic recovery of function was assessed by the recovery of left ventricular 
developed pressure (LVDP) expressed as % of the initial value (LVDP%). Levels of 
phosphorylated and total ~38 MAPK were measured by Western blot analysis. 
Results: LVDP% was 37.2(4.5) in NORM(I/R). 54.9(5.5) in THYR(I/R) and 77.9(4.5) in 
THYR-PC(I/R). ~~005 between all groups. Phosphorylated ~38 MAPK was 1.9 fold 
hrgher in NORM(l) than in THYR(I). pcO.05 and 3.3 fold higher in THYR(I) than in THYR- 
PC(I), pcO.05. At the end of the reperfusron period phosphorylated ~38 MAPK was 1.7 
fold higher in NORM(I/R) than in THYR(I/R), pcO.05; there was no significant difference 
between THYR-IR and THYR-PC-IRConclusion: Thyroxine pretreatment and PC have 
additive cardioprotectwe effect. This protectron might be due to incremental attenuation 
of ~36 MAPK activation during sustained rschaemia. 
1194-97 Comparative Effects of Aspirin With Angiotensin 
Converting Enzyme Inhibitor or Angiotensin Receptor 
Blocker on Myocardial Infarction and Vascular Function 
Boaino Zhu Richard E. Sievers, Amanda E. Browne, Randall J. Lee, Kanu Chatterjee, 
William Grossman, William W. Parmley, University of California San Francisco, San 
Francisco, CA 
Background: We previously showed that an ACE inhibitor (captopnl) or an angiotensin 
receptor blocker (losartan) reduced infarct size and improved endothelial function m a rat 
model of ischemia-repedusion. The present study was undertaken to see if aspirin (ASA) 
antagonized the beneficial effects of captopril or losartan. Methods: 114 Sprague-Dawley 
rats were randomized into 6 groups. Control , ASA, Captopril, Losartan, ASA+Captopril, 
and ASA+Losarian. ASA, Captopril or Losartan were given as 40 mgfkgiday in drinking 
water. After 6 weeks of pretreatment, the rats were subjected to 17 min of LAD occlusion 
and 120 min of repedusion wrth hemodynamic and ECG monitoring. In fresh aortic rings 
precontracted with phenylephrine, endothelium-dependent and -independent relaxation 
were assessed using acetylcholine and nitroglycerin, During the reperfusion period, the 
effective refractory period (ERP), VF threshold (VFT) and bleeding time (BT) were mea- 
sured. Results: Hemodynamic changes were the same. Serum ASA concentrations were 
0.5, 1.1 and 0.6 mgldl in the ASA, ASA+Captopril and ASA+Losartan groups respec- 
tively, and BT were prolonged. ASA reduced endothelium-dependent relaxation, but did 
not change endothelium-independent relaxation. Ang I and ERP were elevated by Capto- 
pril. Ang I, Ang II, ERP, and VFT were elevated by Losartan. Captopril or losartan 
reduced infarct size. Conclusion: Aspirin did not attenuate cardiovascular protective 
effects of captopril or losartan. 
Results (‘PcO.05, **PcO.Ol as compared with the control group) 
Groups 
Control 
ASA 
Infarct size Max-Relax 
(%) (%) 
53*3 -69*11 
40+6 -29t8” 
ERP 
(mS) 
30*1 
34i2 
VFT (mA) BT (set) 
.66*.15 78*7 
.74*.12 185~21~ 
Captopril 
Losartan 
39*4’ -73*9 35*2’ .75+.12 87*6 
39*5 -68r9 43*3” 1.285.23’ 85*16 
* 
ASA+Captorpi 39+3 
I 
ASA+Losartan 42*6 
-63i12 36*1* .87+.10 229*36’ 
. 
-53*9 37*2* 1.07*.19 167228’ 
1194-96 Myocardial lschemia Induced Upregulation of 
Pleiotrophin Gene 
Karen L. Christman Richard Sievers, Qizhr Fang, Kenneth Colley. Randall J. Lee, 
University of California, San Francisco, San Francisco, CA 
BACKGROUND: Pleiotrophm (PTN) is a secreted heparfn-binding cytokine with several 
functions. In vitro, it is known to stimulate mitogenesis and anglogenesis. During brain 
rschemia, upregulation of PTN gene expression was observed. We examined the hypoth- 
esis that PTN gene expression is also upregulated during ischemia in the heart. METH- 
ODS: A rat myocardial infarction model in which the left coronary artery was permanently 
occluded was used. A sham control group and an occlusion group were examined at 30 
min, 3 h, 24 h, 3 d, 7 d and 14 d (n=3 for all groups except 3 h where n=l). The ischemic 
left ventricle (LV) was harvested for RNA isolation and RT-PCR analysis. PTN mRNA 
signals were evaluated with densitometry and normalized using bands of known mass in 
a molecular weight standard. 
RESULTS: PTN mRNA levels were significantly increased after 3, 7 and 14 days in the 
ischemic LV. Data in the graph below represent mean PTN mRNA level f S.D. (’ ~‘0.05 
vs. control, t-test; ** ~~0.05 vs. control, t-test, and vs. 30m, 3h, and 24h occlusion, one- 
way ANOVA.) 
CONCLUSION: PTN gene expression is upregulated in the ischemic heart and follows a 
similar time course as during ischemia in the brain. AS a growth factor known to be 
mvolved in angiogenesrs in vitro, PTN may also play a role in angiogenesis in ischemic 
myocardium. 
